The role of SOCS3 in modulating leukaemia inhibitory factor signalling during murine placental development
Authors:
- 3 April 2007
- journal article
- review article
- Published by Elsevier in Journal of Reproductive Immunology
- Vol. 77 (1) , 1-6
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- SOCS-3 negatively regulates innate and adaptive immune mechanisms in acute IL-1-dependent inflammatory arthritisJournal of Clinical Investigation, 2006
- Suppressors of cytokine signaling proteins in human preterm placental tissuesJournal of Molecular Endocrinology, 2005
- TheRole ofSuppressors ofCytokineSignaling(SOCS) Proteins inRegulation of theImmuneResponseAnnual Review of Immunology, 2004
- SOCS3 Is a Critical Physiological Negative Regulator of G-CSF Signaling and Emergency GranulopoiesisImmunity, 2004
- IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophagesNature Immunology, 2003
- CIS3/SOCS-3 Suppresses Erythropoietin (EPO) Signaling by Binding the EPO Receptor and JAK2Journal of Biological Chemistry, 2000
- SOCS-3 Is an Insulin-induced Negative Regulator of Insulin SignalingJournal of Biological Chemistry, 2000
- Localization of Leukemia Inhibitory Factor and Its Receptor in Human Placenta Throughout Pregnancy1Biology of Reproduction, 1999
- The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat familiesGenes & Development, 1998
- Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease.BMJ, 1989